ResearcherHamamatsu University School of MedicineActive in the last 2 years

Takafumi Suda

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5300-0504; OpenAlex author ID A5106084426. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 1 paper

Papers 1

Prognostic value of neutrophil to lymphocyte ratio in patients with advanced pancreatic ductal adenocarcinoma treated with systemic chemotherapy. Last author DOI 10.1080/07853890.2024.2398725 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yoshifumi Morita · 1 shared paper, 2024 · strength 0.17
- Paper Prognostic value of neutrophil to lymphocyte ratio in patients with advanced pancreatic ductal adenocarcinoma treated w… DOI 10.1080/07853890.2024.2398725 ↗
Satoru Furuhashi · 1 shared paper, 2024 · strength 0.17
- Paper Prognostic value of neutrophil to lymphocyte ratio in patients with advanced pancreatic ductal adenocarcinoma treated w… DOI 10.1080/07853890.2024.2398725 ↗
Kensuke Kitsugi · 1 shared paper, 2024 · strength 0.17
- Paper Prognostic value of neutrophil to lymphocyte ratio in patients with advanced pancreatic ductal adenocarcinoma treated w… DOI 10.1080/07853890.2024.2398725 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.